-+ 0.00%
-+ 0.00%
-+ 0.00%

Sofwave Announces Publication of Data from Randomized Controlled Study of its Pure Impact™ VIP Platform Utilizing PlyoPulse™ EMS Technology in Aesthetic Surgery Journal

Barchart·08/31/2026 07:00:00
Listen to the news

SAN CLEMENTE, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd. (TASE: SOFW), a global regenerative aesthetics company advancing non-invasive technologies for skin and body, today announced the publication of data from a new randomized controlled clinical study of the Company’s proprietary PlyoPulse technology, titled “Functional Performance, Subject-Body Perception, and Safety Following Multi-Muscle Electromuscular Stimulation: A Randomized Controlled Study,” in the September issue of Aesthetic Surgery Journal. The results demonstrated that PlyoPulse, delivered through the Pure Impact VIP platform, produced statistically significant improvements in objective functional muscle performance, sustained through the four-week follow-up.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.